Company Filing History:
2 out of 10 
2 out of 4 Years Active: 2023-2025
Title: Nicklas Bassani: Innovator in Cancer Biomarkers
Introduction
Nicklas Bassani is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of cancer research, particularly in the area of biomarkers. With a total of 2 patents, his work focuses on improving cancer detection and treatment.
Latest Patents
One of Nicklas Bassani's latest patents is centered around the use of platelet-derived endothelial cell growth factor (PD-ECGF) as a biomarker for cancer. This invention aims to enhance the prediction of cancer detection, diagnosis, and monitoring. It also seeks to provide insights into the response to anti-angiogenic treatment. The application of PD-ECGF levels is intended to serve as a valuable tool in monitoring disease evolution and predicting treatment outcomes.
Career Highlights
Throughout his career, Nicklas has worked with esteemed organizations such as the Catalan Institute of Oncology and the Bellvitge Biomedical Research Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field of oncology and biomedical research.
Collaborations
Nicklas has collaborated with notable colleagues, including Oriol Casanovas Casanovas and Gabriela Jiménez Valerio. These partnerships have contributed to the advancement of his research and the development of innovative solutions in cancer treatment.
Conclusion
Nicklas Bassani's work in cancer biomarkers exemplifies the impact of innovation in medical research. His contributions are paving the way for improved cancer detection and treatment strategies.